Dronabinol Naltrexone Treatment for Opioid Dependence
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The goal of this two-year study is to test the efficacy of dronabinol as an adjunct to
maintenance treatment with naltrexone in opioid-dependent individuals. We hypothesize that
administering dronabinol during detoxification and during the first few weeks of naltrexone
treatment will lead to improved naltrexone tolerability, resulting in better naltrexone
compliance and treatment retention, and ultimately a reduction in opioid use and relapse
rates.